ACTIVE

PRIMARY CARE DIABETES EUROPE

Financial year 2024 · Closed on 31/12/2024

Net result-122 k €-604,1 %over 1 year
Revenue53,6 k €-23,2 %over 1 year
Equity316,2 k €-13,2 %over 1 year

Identity

Source · BCE/KBO

PRIMARY CARE DIABETES EUROPE is a International non-profit organization incorporated in 2005. Its registered office is in Antwerpen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0871.319.821
Incorporation
10/01/2005
Legal form
International non-profit organization
Registered office
Bredestraat 79
2180 Antwerpen · FlandreSee on map
Latest accounts
31/12/2024
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 7 filings

Trend over 6 financial years

20242022202120202019
Income statement
Revenue53,6 k €69,8 k €–––
EBITDA-125,5 k €-18 k €-54,5 k €-32 k €115 k €
Operating result-125,5 k €-18 k €-54,5 k €-32 k €115 k €
Net result-122 k €-17,3 k €-52 k €-34,4 k €115 k €
Balance sheet
Equity316,2 k €364,3 k €381,6 k €433,6 k €467,9 k €
Total assets348,6 k €448,3 k €467,4 k €504,6 k €470,2 k €
Cash313,8 k €415,9 k €414,7 k €504,6 k €470,2 k €
Debts29,6 k €52,6 k €10,4 k €7 k €2,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

5 active · 1 ended

Active mandates

Antonio Gerardo Medea

Director

Active
Philip Domeyer

Director

Active
Pinar Topsever

Vice-chairman of the board of directors

Active
Samuel Seidu

Director

Active
Xavier Cos

Chairman of the board of directors

Active

Ended mandates

Philp Domeyer

Director

Ended

Other companies at this address

Bredestraat 79 2180 Antwerpen
CompanyCBE no.
0768.329.575

Full financial information

Source · NBB
202420222021202020192018
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelAbridged model
Start of the financial year01/01/202401/01/202201/01/202101/01/202001/01/201901/01/2018
Closing of the financial year31/12/202431/12/202231/12/202131/12/202031/12/201931/12/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date19/01/202623/08/202309/03/202209/03/202225/03/202213/03/2022
General meeting15/12/202514/06/202304/03/202204/03/202204/03/202204/03/2022
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 7 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro modelCorrection31/12/202415/12/202519/01/2026DutchPDF
Micro model31/12/202416/07/202528/07/2025DutchPDF
Micro model31/12/202214/06/202323/08/2023DutchPDF
Micro model31/12/202104/03/202209/03/2022DutchPDF
Micro model31/12/202004/03/202209/03/2022DutchPDF
Micro model31/12/201904/03/202225/03/2022DutchPDF
Abridged model31/12/201804/03/202213/03/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

5 active · 1 ended

Active mandates

Antonio Gerardo Medea

Director

Active
Philip Domeyer

Director

Active
Pinar Topsever

Vice-chairman of the board of directors

Active
Samuel Seidu

Director

Active
Xavier Cos

Chairman of the board of directors

Active

Ended mandates

Philp Domeyer

Director

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • 26/08/2026
    —
    PDF
  • Other04/08/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates06/12/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/12/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/03/2009
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/02/2007
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other19/01/2005
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-122 k €↓
  2. 2024
    Name changePrimary Care Diabetes Europe (PCD Europe)
  3. 2022
    Annual accounts 2022-17,3 k €↑
  4. 2022
    Name changePrimary Care Diabetes Europe (PCDE)
  5. 2021
    Annual accounts 2021-52 k €↓
  6. 2020
    Annual accounts 2020-34,4 k €↓
  7. 2019
    Annual accounts 2019115 k €↑
  8. 2018
    Annual accounts 201886,3 k €
  9. 10/01/2005
    IncorporationInternational non-profit organization